Overview

Imaging of Brain Amyloid Plaques in the Aging Population

Status:
Enrolling by invitation
Trial end date:
2023-04-01
Target enrollment:
Participant gender:
Summary
This is a prospective, open label, non-therapeutic, diagnostic imaging study. The purpose of this study is to utilize Pittsburgh Compound B positron emission imaging (PiB PET) to ascertain the relationship between change in amyloid burden over time, and concurrent change in clinical status.
Phase:
Phase 4
Details
Lead Sponsor:
Mayo Clinic
Collaborator:
National Institute on Aging (NIA)
Treatments:
Corticosterone